Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Sage Therapeutics, Inc.    SAGE

SAGE THERAPEUTICS, INC.

(SAGE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about SAGE THERAPEUTICS, INC.
03/02SAGE THERAPEUTICS  : Morgan Stanley Adjusts Sage Therapeutics PT to $87 From $83..
MT
02/26SAGE THERAPEUTICS  : Mizuho Downgrades Sage Therapeutics to Neutral from Buy, Se..
MT
02/25SAGE THERAPEUTICS  : Oppenheimer Adjusts Sage Therapeutics PT to $102 From $90, ..
MT
02/25SAGE THERAPEUTICS  : RBC Adjusts Sage Therapeutics' Price Target to $89 From $86..
MT
02/24SAGE THERAPEUTICS  : Swings to Profit, Posts Higher Revenue in Q4
MT
02/24SAGE THERAPEUTICS  : Announces Fourth Quarter and Full Year 2020 Financial Resul..
BU
02/24SAGE THERAPEUTICS  : Earnings Flash (SAGE) SAGE THERAPEUTICS Reports Q4 Revenue ..
MT
02/11SAGE THERAPEUTICS  : to Present at Upcoming Investor Conferences
BU
02/10SAGE THERAPEUTICS  : to Report Fourth Quarter and Full Year 2020 Financial Resul..
BU
02/02SAGE THERAPEUTICS  : Raymond James Reinstates Sage Therapeutics at Market Perfor..
MT
01/22SAGE THERAPEUTICS  : BMO Capital Downgrades Sage Therapeutics to Market Perform ..
MT
01/19SAGE THERAPEUTICS  : Wedbush Adjusts Price Target on Sage Therapeutics to $98 Fr..
MT
01/07SAGE THERAPEUTICS  : Provides 2021 Corporate Strategy Update at J.P. Morgan Heal..
BU
01/04SAGE THERAPEUTICS  : Guggenheim Upgrades Sage Therapeutics to Buy From Neutral, ..
MT
01/04SAGE THERAPEUTICS  : RBC Downgrades Sage Therapeutics to Sector Perform From Out..
MT
More most relevant news
All news about SAGE THERAPEUTICS, INC.
03/02SAGE THERAPEUTICS  : Morgan Stanley Adjusts Sage Therapeutics PT to $87 From $83..
MT
02/26SAGE THERAPEUTICS  : Mizuho Downgrades Sage Therapeutics to Neutral from Buy, Se..
MT
02/25SAGE THERAPEUTICS  : Oppenheimer Adjusts Sage Therapeutics PT to $102 From $90, ..
MT
02/25SAGE THERAPEUTICS  : RBC Adjusts Sage Therapeutics' Price Target to $89 From $86..
MT
02/24SAGE THERAPEUTICS  : Swings to Profit, Posts Higher Revenue in Q4
MT
02/24SAGE THERAPEUTICS  : Management's Discussion and Analysis of Financial Condition..
AQ
02/24SAGE THERAPEUTICS, INC.  : Results of Operations and Financial Condition, Financ..
AQ
02/24SAGE THERAPEUTICS  : Announces Fourth Quarter and Full Year 2020 Financial Resul..
BU
02/24SAGE THERAPEUTICS  : Earnings Flash (SAGE) SAGE THERAPEUTICS Reports Q4 Revenue ..
MT
02/11SAGE THERAPEUTICS  : to Present at Upcoming Investor Conferences
BU
More news
News in other languages on SAGE THERAPEUTICS, INC.
2019Wall Street finit en hausse après une séance hésitante
2019SAGE THERAPEUTICS, INC.  : massacre en vue à Wall Street
2019AVIS D'ANALYSTES DU JOUR  : Air France, BNP Paribas, Teleperformance, DBV Techno..
2019STOCK MARKET PARIS : La Fed choisit la sobriété
2019STOCK MARKET PARIS : Et si l'Allemagne aidait la BCE à relancer la croissance ?
2019EN DIRECT DES MARCHES : Air France KLM, Renault, Vallourec, Scor, Google, Rep..
2019BB Biotech creuse sa perte au deuxième trimestre
2019AVIS D'ANALYSTES DU JOUR  : Accor, ArcelorMittal, Danone, Novartis, Sika, Sunris..
2019STOCK MARKET PARIS : La Chine met les Terres Rares dans la balance
2019AVIS D'ANALYSTES DU JOUR  : Hermès, Lagardère, Maurel & Prom, Michelin, TechnipF..
More news
Analyst Recommendations on SAGE THERAPEUTICS, INC.
03/02SAGE THERAPEUTICS  : Morgan Stanley Adjusts Sage Therapeutics PT to $87 From $83..
MT
02/26SAGE THERAPEUTICS  : Mizuho Downgrades Sage Therapeutics to Neutral from Buy, Se..
MT
02/25SAGE THERAPEUTICS  : Oppenheimer Adjusts Sage Therapeutics PT to $102 From $90, ..
MT
02/25SAGE THERAPEUTICS  : RBC Adjusts Sage Therapeutics' Price Target to $89 From $86..
MT
02/02SAGE THERAPEUTICS  : Raymond James Reinstates Sage Therapeutics at Market Perfor..
MT
More recommendations
Press releases
02/24SAGE THERAPEUTICS  : Management's Discussion and Analysis of Financial Condition..
AQ
02/24SAGE THERAPEUTICS, INC.  : Results of Operations and Financial Condition, Financ..
AQ
02/24SAGE THERAPEUTICS  : Announces Fourth Quarter and Full Year 2020 Financial Resul..
BU
02/11SAGE THERAPEUTICS  : to Present at Upcoming Investor Conferences
BU
02/10SAGE THERAPEUTICS  : to Report Fourth Quarter and Full Year 2020 Financial Resul..
BU
More press releases
Upcoming event on SAGE THERAPEUTICS, INC.